Tse, Gary
Hong Kong Metropolitan University,
Hong Kong
2025 Rank: 23158
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 678 out of 235606 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23158 | 17974 |
| Total Cites | 1873 | 2235 |
| H-index | 16 | 17 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 22 | 25 |
| Number of Single+First Authored Papers | 74 | 74 |
| Total Cites to Single+First Authored Papers | 182 | 228 |
| Number of Single+First+Last Authored Papers | 157 | 157 |
| Total Cites to Single+First+Last Authored Papers | 352 | 504 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1662 | 1761 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.27 |
| Self-Citation Percentage |
16.20%
|
|
Tse, Gary
Hong Kong Metropolitan University,
Hong Kong
2024 Rank: 23270
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 727 out of 224060 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23270 | 16457 |
| Total Cites | 1535 | 1992 |
| H-index | 17 | 18 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 26 | 29 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 170 | 232 |
| Number of Single+First+Last Authored Papers | 141 | 141 |
| Total Cites to Single+First+Last Authored Papers | 344 | 546 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1393 | 1496 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.33 |
| Self-Citation Percentage |
22.94%
|
|
Tse, Gary
The Second Hospital of Tianjin Medical University,
China
2023 Rank: 23438
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 775 out of 210400 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23438 | 18414 |
| Total Cites | 1414 | 1715 |
| H-index | 16 | 17 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 28 | 32 |
| Number of Single+First Authored Papers | 66 | 66 |
| Total Cites to Single+First Authored Papers | 188 | 245 |
| Number of Single+First+Last Authored Papers | 120 | 120 |
| Total Cites to Single+First+Last Authored Papers | 324 | 480 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1294 | 1398 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.23 |
| Self-Citation Percentage |
17.55%
|
|
Tse, Gary
The Second Hospital of Tianjin Medical University,
China
2022 Rank: 27841
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 874 out of 199278 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27841 | 20182 |
| Total Cites | 1169 | 1473 |
| H-index | 15 | 17 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 19 | 21 |
| Number of Single+First Authored Papers | 64 | 64 |
| Total Cites to Single+First Authored Papers | 198 | 283 |
| Number of Single+First+Last Authored Papers | 99 | 99 |
| Total Cites to Single+First+Last Authored Papers | 307 | 445 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1051 | 1127 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.31 |
| Self-Citation Percentage |
20.64%
|
|
Tse, Gary
The Second Hospital of Tianjin Medical University,
China
2021 Rank: 35935
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1077 out of 192021 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35935 | 27205 |
| Total Cites | 1331 | 1631 |
| H-index | 17 | 18 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 30 | 36 |
| Number of Single+First Authored Papers | 60 | 60 |
| Total Cites to Single+First Authored Papers | 263 | 356 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 362 | 493 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1215 | 1312 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.24 |
| Self-Citation Percentage |
18.39%
|
|
Tse, Gary
The Second Hospital of Tianjin Medical University,
China
2020 Rank: 48074
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1335 out of 152312 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 48074 | 35915 |
| Total Cites | 681 | 867 |
| H-index | 11 | 12 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 30 | 37 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 200 | 275 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 249 | 336 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 614 | 685 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.27 |
| Self-Citation Percentage |
21.45%
|
|